FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	Max-40279 Sensitive: D – Preclinical Max-40279 Sensitive : D	Max-40279 Sensitive: D – Preclinical Max-40279 Sensitive : D
FLT3 D835Y	Acute Myelogenous Leukemia	FLT3 D835Y	Acute Myelogenous Leukemia	Max-40279 Sensitive: D – Preclinical Max-40279 Sensitive : D	Max-40279 Sensitive: D – Preclinical Max-40279 Sensitive : D
JAK3 M511I	T Acute Lymphoblastic Leukemia	JAK3 M511I	T Acute Lymphoblastic Leukemia	tofacitinib XR Sensitive: D – Preclinical tofacitinib XR Sensitive : D	tofacitinib XR Sensitive: D – Preclinical tofacitinib XR Sensitive : D
MYB-TYK2 fusion	B Acute Lymphoblastic Leukemia	MYB-TYK2 fusion	B Acute Lymphoblastic Leukemia	ALXN2075 Sensitive: D – Preclinical ALXN2075 Sensitive : D	ALXN2075 Sensitive: D – Preclinical ALXN2075 Sensitive : D
GOLGA4-JAK2 fusion	B Acute Lymphoblastic Leukemia	GOLGA4-JAK2 fusion	B Acute Lymphoblastic Leukemia	JAK inhibitor Sensitive: D – Preclinical JAK inhibitor Sensitive : D	JAK inhibitor Sensitive: D – Preclinical JAK inhibitor Sensitive : D
MYB-TYK2 fusion	B Acute Lymphoblastic Leukemia	MYB-TYK2 fusion	B Acute Lymphoblastic Leukemia	vorinostat + ALXN2075 Sensitive: D – Preclinical vorinostat + ALXN2075 Sensitive : D	vorinostat + ALXN2075 Sensitive: D – Preclinical vorinostat + ALXN2075 Sensitive : D

JAK inhibitor

Associations(6)